UNSPSC 51402301: Mepiprazole

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 977BAL0NR7. European Medicines Agency schedules Mepiprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08751MIG. Mepiprazole generally arises in the molecular formula C16H21CLN4. The term MEPIPRAZOLE is an International Non-Proprietary Name or INN. MEPIPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule mepiprazole under HS 29335995 and SITC 51576. As of Q4 2014, MEPIPRAZOLE remains the US FDA Preferred Term for this commodity. Mepiprazole bears US NLM identifiers UMLS ID C0065963 and NCI Concept Code C66092. SMILES: Clc1cc(N2CCN(CC2)CCc2n[nH]c(c2)C)ccc1.

UNSPSC 51402301 Mepiprazole (Commodity) does not align with the recent state and local procurement activity tagged under this code. The three most recent opportunities—naloxone procurement by Seminole County, a Texas HHS direct-to-manufacturer pharmacy initiative RFI, and a Minnesota multistate cooperative generic pharmaceuticals RFP—span emergency-response medications, pharmacy benefit program design, and broad OTC and generic drug supply, none of which match mepiprazole, an atypical antipsychotic. The code shows little relevant recent activity in state and local procurement when measured against what is actually being solicited.

The mismatch between the code's nominal scope and the opportunities posted under it reflects either tagging error or the code's minimal use in state and local procurement. Practitioners evaluating this code should verify the underlying commodity or service line against current solicitations before committing bid resources, as the taxonomy label does not reliably predict the work state and local governments are currently buying.